285 related articles for article (PubMed ID: 32209427)
1. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
[TBL] [Abstract][Full Text] [Related]
2. N-Glycome changes reflecting resistance to platinum-based chemotherapy in ovarian cancer.
Zahradnikova M; Ihnatova I; Lattova E; Uhrik L; Stuchlikova E; Nenutil R; Valik D; Nalezinska M; Chovanec J; Zdrahal Z; Vojtesek B; Hernychova L; Novotny MV
J Proteomics; 2021 Jan; 230():103964. PubMed ID: 32898699
[TBL] [Abstract][Full Text] [Related]
3. Sialic acid linkage-specific permethylation for improved profiling of protein glycosylation by MALDI-TOF MS.
Jiang K; Zhu H; Li L; Guo Y; Gashash E; Ma C; Sun X; Li J; Zhang L; Wang PG
Anal Chim Acta; 2017 Aug; 981():53-61. PubMed ID: 28693729
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
5. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
[TBL] [Abstract][Full Text] [Related]
6. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric screening of ovarian cancer with serum glycans.
Kim JH; Park CW; Um D; Baek KH; Jo Y; An H; Kim Y; Kim TJ
Dis Markers; 2014; 2014():634289. PubMed ID: 24648610
[TBL] [Abstract][Full Text] [Related]
8. Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer.
Kudelka MR; Lasanajak Y; Smith DF; Song X; Hossain MS; Owonikoko TK
Cancer Med; 2023 Mar; 12(6):6768-6777. PubMed ID: 36437732
[TBL] [Abstract][Full Text] [Related]
9. MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.
Briggs MT; Condina MR; Ho YY; Everest-Dass AV; Mittal P; Kaur G; Oehler MK; Packer NH; Hoffmann P
Proteomics; 2019 Nov; 19(21-22):e1800482. PubMed ID: 31364262
[TBL] [Abstract][Full Text] [Related]
10. Comparative glycomic profiling in esophageal adenocarcinoma.
Hammoud ZT; Mechref Y; Hussein A; Bekesova S; Zhang M; Kesler KA; Novotny MV
J Thorac Cardiovasc Surg; 2010 May; 139(5):1216-23. PubMed ID: 20412957
[TBL] [Abstract][Full Text] [Related]
11. Generalized low levels of serum N-glycans associate with better health status.
Fan J; Sha J; Chang S; Zhao H; Niu X; Gu Y; Gu J; Ren S
Aging Cell; 2023 Jul; 22(7):e13855. PubMed ID: 37132100
[TBL] [Abstract][Full Text] [Related]
12. The ascites N-glycome of epithelial ovarian cancer patients.
Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
[TBL] [Abstract][Full Text] [Related]
13. Altered N-linked glycosylation in endometrial cancer.
Mittal P; Briggs M; Klingler-Hoffmann M; Kaur G; Packer NH; Oehler MK; Hoffmann P
Anal Bioanal Chem; 2021 Apr; 413(10):2721-2733. PubMed ID: 33222001
[TBL] [Abstract][Full Text] [Related]
14. Differential
Yaman ME; Kayili HM; Albayrak M; Kadioglu Y; Salih B
Mol Omics; 2021 Jun; 17(3):394-404. PubMed ID: 33735360
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans.
Park CW; Jo Y; Jo EJ
Anal Biochem; 2013 Dec; 443(1):58-65. PubMed ID: 23969014
[TBL] [Abstract][Full Text] [Related]
16. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
17. Tear N-glycomics in vernal and atopic keratoconjunctivitis.
Messina A; Palmigiano A; Tosto C; Romeo DA; Sturiale L; Garozzo D; Leonardi A
Allergy; 2021 Aug; 76(8):2500-2509. PubMed ID: 33583051
[TBL] [Abstract][Full Text] [Related]
18. N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.
Leijon H; Kaprio T; Heiskanen A; Satomaa T; Hiltunen JO; Miettinen MM; Arola J; Haglund C
J Clin Endocrinol Metab; 2017 Nov; 102(11):3990-4000. PubMed ID: 28938401
[TBL] [Abstract][Full Text] [Related]
19. N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry.
Otto VI; Damoc E; Cueni LN; Schürpf T; Frei R; Ali S; Callewaert N; Moise A; Leary JA; Folkers G; Przybylski M
Glycobiology; 2006 Nov; 16(11):1033-44. PubMed ID: 16877748
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the site-specific N-glycosylation of beta1,6 N-acetylglucosaminyltransferase V.
Kamar M; Alvarez-Manilla G; Abney T; Azadi P; Kumar Kolli VS; Orlando R; Pierce M
Glycobiology; 2004 Jul; 14(7):583-92. PubMed ID: 15084511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
